Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series.

Minkove, Samuel J; Geiger, Grant; Llibre, Josep M; Montgomery, Mary W; West, Natalie E; Chida, Natasha M; Antar, Annukka A R; Dandachi, Dima; Weld, Ethel D

Minkove, Samuel J; Geiger, Grant; Llibre, Josep M; Montgomery, Mary W; West, Natalie E; Chida, Natasha M; Antar, Annukka A R; Dandachi, Dima; Weld, Ethel D.

Affiliation

Minkove SJ; Department of Medicine, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Osler 508, Baltimore, MD, 21287, USA.
Geiger G; Critical Care Medicine Department, National Institutes of Health, Bethesa, USA.
Llibre JM; University of Missouri-Columbia School of Medicine, Columbia, USA.
Montgomery MW; Infectious Diseases and Fight AIDS Foundation, University Hospital Germans Trias, Badalona, Spain.
West NE; Department of Infectious Diseases, Brigham and Women's Hospital, Boston, USA.
Chida NM; Department of Medicine, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Osler 508, Baltimore, MD, 21287, USA.
Antar AAR; Department of Medicine, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Osler 508, Baltimore, MD, 21287, USA.
Dandachi D; Department of Medicine, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Osler 508, Baltimore, MD, 21287, USA.
Weld ED; Department of Medicine, University of Missouri, Columbia, USA.

AIDS Res Ther ; 19(1): 6, 2022 02 11.

Article in En | MEDLINE | ID: mdl-35148782

Subject(s)

COVID-19 Drug Treatment; HIV Infections; Receptors, Interleukin-6/antagonists & inhibitors; HIV Infections/drug therapy; Hospitalization; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Receptors, Interleukin-6 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: AIDS Res Ther Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google